Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Dexamethasone Sodium Phosphate in Laryngeal Neoplasms: NCT07760272 Clinical Landscape Report 2026
18 September 2026
NCT07760272 clinical landscape for Laryngeal Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Floxuridine in Colorectal Liver Metastases: NCT07764497 Clinical Landscape Report 2026
18 September 2026
NCT07764497 clinical landscape for Colorectal Liver Metastases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ascorbic Acid in Rectal Adenocarcinoma: NCT07765667 Clinical Landscape Report 2026
18 September 2026
NCT07765667 clinical landscape for Rectal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Metformin Hydrochloride in Diabetes Mellitus, Type 2: NCT07768280 Clinical Landscape Report 2026
18 September 2026
NCT07768280 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mazdutide in Diabetes Mellitus, Type 2: NCT07767552 Clinical Landscape Report 2026
18 September 2026
NCT07767552 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NNC0721-8060 in Obesity: NCT07767175 Clinical Landscape Report 2026
18 September 2026
NCT07767175 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Retlirafusp alfa in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07769866 Clinical Landscape Report 2026
18 September 2026
NCT07769866 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Retlirafusp alfa in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07770672 Clinical Landscape Report 2026
18 September 2026
NCT07770672 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Atorvastatin Calcium in Medication interactions: NCT07785934 Clinical Landscape Report 2026
18 September 2026
NCT07785934 clinical landscape for Medication interactions: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Locally Advanced Rectal Carcinoma: NCT07769853 Clinical Landscape Report 2026
18 September 2026
NCT07769853 clinical landscape for Locally Advanced Rectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Empagliflozin/metformin Hydrochloride in Diabetes Mellitus, Type 2: NCT07771010 Clinical Landscape Report 2026
18 September 2026
NCT07771010 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pucotenlimab in Squamous cell carcinoma of the oral cavity: NCT07766889 Clinical Landscape Report 2026
18 September 2026
NCT07766889 clinical landscape for Squamous cell carcinoma of the oral cavity: endpoints, sponsor, phase, geography, readouts, asset context and development…